Phase II Trial of Allovectin-7® for Metastatic Melanoma
NCT00044356
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
133
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Metastatic Melanoma
Malignant Melanoma
Skin Cancer
Interventions
GENETIC:
Allovectin-7®
Sponsor
Vical